Pf Vax XMK

1.28 k
Primary Application
Imprint
For what
Immune and Lymphatic
Source
Homeopathy
For whom
People

This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reactions from the vaccine. For lower potency, use "Pf Vax 30K", "Pf Vax 200K", or "Pf Vax MK".


Pf Vax XMK
Replies
R
Nov 05, 2021
Is there one for Johnson and Johnson?
1 reply
Hide branch
Show modal
Similar ICs
Imprint This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reaction...
Imprint This IC was made with the help of a highly diluted solution of the mRNA-based vaccine. It may be used to help ease side effects and adverse reactio...
Imprint This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reaction...
Imprint This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reaction...
Imprint This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reaction...
Imprint This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reaction...
Imprint This IC was made with the help of a highly diluted solution of an mRNA-based vaccine. It may be used to help ease side effects and adverse reaction...
Imprint This IC was made with the help of an mRNA-based vaccine. It may be used to help ease side effects and adverse reactions from the vaccine. This home...
Imprint This IC was made with the help of a highly diluted solution of a viral vector-based vaccine. It may be used to help ease side effects and adverse r...
Imprint Pneumococcal-13 Vax XMK is a homeopathic remedy made from the pneumococcal vaccine containing a sterile solution of saccharides of capsular antigen...